Elixir Medical Receives CE Mark Approval for the DESyne BD Novolimus Eluting Coronary Stent System With Biodegradable Polymer Coating

Elixir Medical Corporation, a developer of product platforms that combine state-of-the-art medical devices with advanced pharmaceuticals, announced that it has received CE (Conformité Européenne) Mark approval for its DESyne BD Novolimus Eluting Coronary Stent System for the treatment of coronary artery disease.
Heraldonline.com